Core Insights - PTC Therapeutics reported a revenue of $164.68 million for Q4 2025, marking a year-over-year decline of 22.8% and significantly missing the Zacks Consensus Estimate of $304.72 million by 45.96% [1] - The company experienced an EPS of -$1.67, which is a substantial drop from -$0.24 a year ago, resulting in an EPS surprise of -700.58% compared to the consensus estimate of -$0.21 [1] Revenue Breakdown - Net product revenue reached $183.99 million, exceeding the four-analyst average estimate of $174.53 million, reflecting an 18.9% year-over-year increase [4] - Royalty revenue was reported at $79.39 million, surpassing the average estimate of $70.77 million, with a year-over-year change of 36.5% [4] - Net product revenue from Translarna was $39 million, slightly below the average estimate of $40.42 million, showing a significant decline of 58.4% year-over-year [4] - Net product revenue from Emflaza was $27.1 million, which is lower than the estimated $29.58 million, representing a 46.3% decrease compared to the previous year [4] - Collaboration and license revenue was reported at -$0.07 million, a stark contrast to the average estimate of $118.82 million [4] Stock Performance - PTC Therapeutics shares have returned -8.8% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Financial Performance - Floor & Decor reported revenue of $1.13 billion for the quarter ended December 2025, reflecting a year-over-year increase of 2% [1] - The earnings per share (EPS) for the same period was $0.36, down from $0.39 a year ago [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $1.14 billion, resulting in a surprise of -0.52% [1] - The company delivered an EPS surprise of +1.9%, with the consensus EPS estimate being $0.35 [1] Key Metrics - Comparable store sales decreased by 4.8%, compared to an average estimate of -3% from seven analysts [4] - The total number of warehouse stores was 270, slightly below the average estimate of 272 based on four analysts [4] - The number of warehouse stores opened was 8, compared to an estimated 9 by three analysts [4] Stock Performance - Shares of Floor & Decor have returned -6.8% over the past month, while the Zacks S&P 500 composite experienced a -0.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Viewpoint - ICU Medical reported a revenue of $535.94 million for the quarter ended December 2025, reflecting a 13.8% decline year-over-year, with an EPS of $1.91 compared to $2.11 in the same quarter last year [1] Financial Performance - The reported revenue of $535.94 million exceeded the Zacks Consensus Estimate of $528.97 million, resulting in a surprise of +1.32% [1] - The company achieved an EPS surprise of +13.52%, with the consensus EPS estimate being $1.68 [1] Key Metrics - Revenue from Infusion Systems was $176.3 million, slightly below the average estimate of $177.59 million from two analysts [4] - Revenue from Vital Care reached $79.7 million, surpassing the average estimate of $76.87 million from two analysts [4] - Revenue from Consumables was $284.7 million, exceeding the two-analyst average estimate of $280.64 million [4] Stock Performance - Shares of ICU Medical have returned -2.3% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

For the quarter ended December 2025, American Homes 4 Rent (AMH) reported revenue of $454.99 million, up 4.2% over the same period last year. EPS came in at $0.47, compared to $0.33 in the year-ago quarter.The reported revenue represents a surprise of -1.59% over the Zacks Consensus Estimate of $462.36 million. With the consensus EPS estimate being $0.47, the EPS surprise was +0.56%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to d ...

Core Viewpoint - Altisource Portfolio Solutions S.A. is set to report its earnings for the fourth quarter of 2025 on March 4, 2026, with a press release and presentation available on its Investor Relations website [1]. Group 1: Earnings Report - The earnings report for the fourth quarter of 2025 will be released on March 4, 2026 [1]. - A conference call to discuss the results will take place at 8:30 a.m. EST on the same day [2]. - A replay of the conference call will be accessible approximately two hours after the call and will remain available for about 30 days [2]. Group 2: Company Overview - Altisource Portfolio Solutions S.A. operates as an integrated service provider and marketplace for the real estate and mortgage industries [3]. - The company combines operational excellence with innovative services and technologies to address the demands of changing markets [3].

Core Insights - Wayfair Inc. reported fourth-quarter earnings that surpassed analyst expectations, with adjusted earnings per share of $0.85 compared to the estimate of $0.68, but shares fell over 10% intra-day due to cautious investor sentiment [1] Financial Performance - Revenue for the fourth quarter totaled $3.3 billion, which was in line with consensus estimates and represented a year-over-year increase of 6.9% [1] - U.S. net revenue increased by 7.4% to $2.9 billion, while international revenue rose by 3.7% to $395 million; excluding the impact of exiting Germany, total net revenue would have grown by 7.8% year over year [2] - The company recorded a net loss of $116 million, or $0.89 per diluted share, an improvement from a net loss of $128 million, or $1.02 per share, in the prior-year quarter [2] - Non-GAAP adjusted EBITDA reached $224 million, more than double the $96 million reported in the fourth quarter of 2024 [2] Customer Metrics - Active customers totaled 21.3 million at the end of the quarter, reflecting a decline of 0.5% year over year [3] - Average order value increased to $301 from $290, and net revenue per active customer rose by 5.6% to $586 [3] Annual Performance - For the full year 2025, Wayfair reported total net revenue of $12.5 billion, up 5.1% from 2024, with a net loss of $313 million [3] - Operating cash flow reached $534 million, while free cash flow totaled $329 million for the year [3]

Core Insights - Pediatrix Medical Group's shares fell over 12% following its earnings report, indicating market disappointment with the results [1] Financial Performance - In Q4, Pediatrix reported revenue of nearly $493.8 million, a decrease of almost 2% year-over-year [2] - Non-GAAP net income fell to $42.5 million ($0.50 per share) from $43.5 million in the previous year [2] - Analysts had expected lower revenue of $486.2 million but higher profitability, with a consensus for non-GAAP net income at $0.54 per share [3] Cost and Profitability Concerns - The company's profitability was negatively impacted by increased bonus payouts to practitioners due to a tightening labor market [3] - Despite challenges, Pediatrix has historically managed to deliver growth and maintain decent profits [5] Future Guidance - Pediatrix provided selective guidance, expecting adjusted EBITDA of $280 million to $300 million for full-year 2026, up from $275.6 million the previous year [4] Investment Sentiment - Given the anticipated tepid growth figures, the company is not viewed as a compelling buy, even after the recent price drop [5] - Pediatrix Medical Group was not included in a list of top stocks recommended by analysts, suggesting a cautious outlook for potential investors [6]

Fourth Quarter 2025 Earnings Presentation February 19, 2026 5:00 PM Eastern / 2:00 PM Pacific 4Q25 Registration link 4Q25 Webcast link 1 EXECUTIVE TEAM ON THE CALL STEPHEN BERMAN Chairman & Chief Executive Officer JOHN KIMBLE Executive Vice President & Chief Financial Officer 2 SAFE HARBOR STATEMENT The Company would like to point out that any comments made about JAKKS Pacific's future performance, events or circumstances, including the estimates of sales and/or Adjusted EBITDA in 2026, as well as any other ...

It has been about a month since the last earnings report for Interactive Brokers Group, Inc. (IBKR) . Shares have lost about 1.2% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Interactive Brokers due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.Interactive Brokers Q4 ...

It has been about a month since the last earnings report for Bank OZK (OZK) . Shares have added about 3.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Bank OZK due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Bank OZK before we dive into how investors and analysts have reacted as of late.Bank OZK Q4 Earnings Miss Estimates, Pr ...